Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Wolf

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nucleic Acids Research|March 1, 1996
A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7J J Pink, S Q Wu, D M Wolf, et al.
Journal of Theoretical Biology|September 5, 2001
Automatic discovery of sub-molecular sequence domains in multi-aligned sequences: a dynamic programming algorithm for multiple alignment segmentationE P Xing, D M Wolf, I Dubchak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 5, 2011
Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia BM Serban, A B Skotnicki, M Colovic, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1996
An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptorM M Bilimoria, V J Assikis, H D Muenzner, et al.
Journal of Hematotherapy|May 23, 1998
CD19 selection improves the sensitivity of B cell lymphoma detectionR E Pugh, M A Bitter, E J Shpall, et al.
British Journal of Cancer|December 1, 1991
Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouseY Iino, D M Wolf, S M Langan-Fahey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia AD M Wolf, R Rokicka-Milewska, S Lopaciuk, et al.
Nature Communications|August 10, 2019
Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor typesK Yu, B Chen, D Aran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2020
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survivalM J M Magbanua, L B Swigart, H-T Wu, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nucleic Acids Research|March 1, 1996
A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7J J Pink, S Q Wu, D M Wolf, et al.
Journal of Theoretical Biology|September 5, 2001
Automatic discovery of sub-molecular sequence domains in multi-aligned sequences: a dynamic programming algorithm for multiple alignment segmentationE P Xing, D M Wolf, I Dubchak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 5, 2011
Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia BM Serban, A B Skotnicki, M Colovic, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1996
An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptorM M Bilimoria, V J Assikis, H D Muenzner, et al.
Journal of Hematotherapy|May 23, 1998
CD19 selection improves the sensitivity of B cell lymphoma detectionR E Pugh, M A Bitter, E J Shpall, et al.
British Journal of Cancer|December 1, 1991
Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouseY Iino, D M Wolf, S M Langan-Fahey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia AD M Wolf, R Rokicka-Milewska, S Lopaciuk, et al.
Nature Communications|August 10, 2019
Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor typesK Yu, B Chen, D Aran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2020
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survivalM J M Magbanua, L B Swigart, H-T Wu, et al.
Pageof 3